Cemiplimab improved disease-free survival in patients with high-risk cutaneous squamous cell carcinoma (CSCC) and performed ...

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

Real-world data show no significant differences in overall survival between patients with or without cytogenetic risk factors ...

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...

Vitiligo Awareness Month and World Vitiligo Day aim to educate the public about the autoimmune skin condition's complex ...

The findings support the clinical benefits of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) ...

A combination of acalabrutinib and venetoclax showed better results with the addition of obinutuzumab, whereas mixed findings ...

Bringing this interview with Marla Black Morgan, MD, to a close, she looks to the future of research in both myasthenia ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

A panelist discusses how bleeding risk assessment depends on platelet count levels (highest risk below 20,000), requiring ...